Work

Abstract 5947: Efficacy and safety of lorlatinib in first-line and later-line treatment for Chinese patients: a real-world study with retrospective and prospective bidirectional cohorts

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-5947

Authors: Jiayu Liu, Xin Zhang, Puyuan Xing, Junling Li

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409636374

Cites:

Cited by: 1

Related to: 10